SELENOP and Abdominal obesity: The cluster colored in red combines several terms relative to cardiovascular comorbidities, such as visceral fat, insulin resistance, type-2 diabetes, abdominal obesity, and cardiovascular disease, with metabolic dysfunction and endocrine disorders associated with selenoprotein P, fetuin-A, and fetuin-B.